Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
CrossRef Multi-omics reveals the associations among the fecal metabolome, intestinal bacteria, and serum indicators in patients with hepatocellular carcinoma Jing Feng, Jun-Ping Wang, Jian-Ran Hu, Ping Li, Pin Lv, Hu-Cheng He, Xiao-Wei Cheng, Zheng Cao, Jia-Jing Han, Qiang Wang, Qian Su, Li-Xin Liu World Journal of Gastroenterology .2025;[Epub] CrossRef The crosstalk between gut microbiota and microbiota-derived metabolites in hepatocellular carcinoma Sang Jun Yoon, Seul Ki Han, Tae Suk Kim, Ki Tae Suk, Dae Hee Choi, Young Don Kim, Moon Young Kim, Gab Jin Cheon, Soon Koo Baik, Dong Joon Kim Critical Reviews in Microbiology .2025
Who Should Exercise Extra Caution or Avoid Retatrutide Patients with a history of medullary thyroid carcinoma, MEN2, pancreatitis, severe gastroparesis, or pregnancy should exercise particular caution or avoid retatrutide until further safety data are available
Potential for Long-term Use: Semaglutide has been studied for long-term use in weight management
57 The 3 most common barriers for patients were fear of painful injections, adverse effects of insulin, and the perception that insulin hinted at the end stages of diabetes
Clinical trials have revealed that retatrutide can reduce markers of inflammation, such as C-reactive protein (CRP), which are associated with an increased risk of cardiovascular disease
